Explore 3 Stock Ideas & Industry Insights Download Free Report

News

ReposiTrak's (NYSE:TRAK) Food-Safety Network Expands: Can Recurring Revenue Fuel Growth?

ReposiTrak, Inc. (NYSE:TRAK) closed its fiscal third quarter with operating income up 24% and diluted profit of $0.10 a share, even as flat revenue exposed how a shifting federal deadline can swing bookings. With recurring SaaS revenue above 98% of sales, no bank debt, …

Nitish Kishor | 28 July 2026

Gabelli Multimedia Trust (NYSE: GGT) Expands Share Offering to 22 Million Shares

This ceiling corresponds to a maximum aggregate value of $90,798,487 under a third amendment to the existing sales agreement.

Vinay Lochav | 28 July 2026

Reviva Pharmaceuticals (OTC:RVPH) Pushes Brilaroxazine Toward Its Next Milestone

Reviva Pharmaceuticals Holdings, Inc. (OTC:RVPH) is racing toward two pivotal 2026 readouts for brilaroxazine, its lead schizophrenia candidate, even as it navigates a Nasdaq delisting, a reverse split and a going-concern warning. A March 2026 raise pushed cash to $22.2 million, but that only …

Nitish Kishor | 28 July 2026

HBT Financial (NASDAQ: HBT) Raises Quarterly Dividend 9% to $0.25 Per Share

The decision follows a solid second‑quarter earnings performance. GAAP net income reached $27.8 million, translating to $0.76 per diluted share, compared with $19.2 million a year earlier. This outcome underscores the bank’s ability to generate consistent earnings growth.

Vinay Lochav | 28 July 2026

Sable Offshore (NYSE:SOC) Raises Over $400 Million as California Restart Meets Legal Crossfire

Sable Offshore Corp. (NYSE:SOC) closed concurrent stock and convertible-note offerings on July 2, 2026, generating roughly $439.5 million in net proceeds that, with a new $675 million term loan, retired the ExxonMobil loan financing its Santa Ynez Unit restart. Production off Santa Barbara is …

Nitish Kishor | 28 July 2026

Scienture Holdings (NASDAQ:SCNX) Nears a REZENOPY Launch: Can It Ignite Growth?

Scienture Holdings, Inc. (NASDAQ:SCNX), the specialty pharmaceutical company assembled from the 2024 merger of TRxADE Health and Scienture, Inc., is pushing its FDA-approved naloxone nasal spray REZENOPY toward a commercial debut. A dedicated sales force is set to begin work on June 1, 2026, …

Nitish Kishor | 28 July 2026

Indian Rupee Set for Largest Gain in Three Weeks Amid Declining Oil Prices

The Indian rupee is on track for its steepest rise in three weeks, significantly influenced by a downturn in oil prices and proactive measures from the Reserve Bank of India. This shift is expected to affect energy-dependent sectors, impacting inflation and trade balances positively …

Vinay Lochav | 28 July 2026

Investors Favor Retaining Quarterly Reports Despite Company Pushback

The conversation regarding quarterly reports has intensified as investors express their firm desire to retain these essential financial disclosures. Recent discussions among companies hint at a potential shift away from the standard quarterly reporting requirement, but investor feedback overwhelmingly supports the preservation of this …

Vinay Lochav | 28 July 2026

Kalshi Traders Anticipate Supply Shock Remarks From Fed Chairman Warsh

Federal Reserve Chairman Kevin Warsh is expected to address last week's notable supply shock in an upcoming press conference scheduled for later this week. Traders on Kalshi, a prediction market platform, are tuning in to Warsh’s comments as they anticipate insights that could elucidate …

Vinay Lochav | 28 July 2026

Kustom Entertainment (NASDAQ: KUST) Secures Immediate $250,000 Cash Injection

Kustom Entertainment (NASDAQ: KUST) has amended its divestiture terms with Cycurion, securing a $250,000 immediate cash payment and a total valuation of $6.1 million. This deal signals a significant shift in the company's strategy, focusing on its live entertainment business.

Vinay Lochav | 28 July 2026
Support

Hi! How can we help you today?

Loading…